NIH-funded research R01 grant

Strategies to boost HIV prevention uptake at drinking venues in Kenya and Uganda

Official title: Innovative strategies to promote biomedical HIV prevention uptake and retention among high-risk adults at drinking venues in Kenya and Uganda

Funded at University of California, San Francisco · NIH-11553386 · Data updated 2026-11-12

A research project tests new ways to help adults at high risk for HIV use PrEP/PEP and stay engaged in prevention services, by working with people in alcohol-serving venues in Kenya and Uganda.

More HIV Prevention research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 1, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$85,275
NIH project number3R01AA030464-05S1
Project IDNIH-11553386 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21 and older who use alcohol at venues in Kenya and Uganda and who are at increased risk for HIV.

Less likely to help

Individuals not at risk or not engaging with prevention services at drinking venues may not benefit.

What this research studies

This project aims to increase use and ongoing engagement with HIV prevention services among adults who drink at venues in sub-Saharan Africa. It builds on a multi-disease screening approach to reach people at risk and connect them to PrEP/PEP and related services. The study will test how integrating HIV testing with other health checks in drinking venues affects uptake and retention in prevention programs. The focus is on reducing stigma and improving perceptions of risk to help people stay connected to preventive care.

Why it matters

Potential benefit: If successful, the initiative could lead to more people at risk receiving PrEP/PEP and maintaining preventive care, reducing new HIV infections.

How similar studies have gone: Previous work shows that venue-based outreach can improve uptake of HIV testing and prevention services, but ongoing retention remains challenging and is the focus here.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Chamie, Gabriel — University of California, San Francisco
  • Study coordinator: Chamie, Gabriel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.